The Leader in Cryoablation
In 2001, the Visica® Treatment System was the first system available for cryoablation of fibroadenomas. Since then, our systems have been used to treat thousands of successful cancer cases.
The Visica Treatment Systems are FDA 510 (k) cleared and has been used in over 4,500 patients, to date. Over 22 papers have been published about cryoablation with the Visica 2 Treatment System, showing it to be a viable alternative to surgical resection.